| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/06/2006 | WO2006009888A3 C-met kinase binding proteins |
| 07/06/2006 | WO2006007751A3 Metabolic method to identify flavours and/or fragrances |
| 07/06/2006 | WO2006007472B1 Non-invasive glucose measurement |
| 07/06/2006 | WO2006007202A3 Canine cd20 compositions |
| 07/06/2006 | WO2006004634A3 Citrus sudden death |
| 07/06/2006 | WO2006000830A3 Cells expressing a modified t cell receptor |
| 07/06/2006 | WO2005123111A3 Maxs as modifiers of the axin pathway and methods of use |
| 07/06/2006 | WO2005121787A3 Lat1 transporters expressed in cancer cells |
| 07/06/2006 | WO2005118626A3 Peptides for inducing a ctl and/or htl response to hepatitis c virus |
| 07/06/2006 | WO2005116234A3 Detection and quantification of intracellular pathogens |
| 07/06/2006 | WO2005111231A3 Compositions, kit and one-step method for monitoring compounds having anti-factor xa and/or anti factor iia activities |
| 07/06/2006 | WO2005076781A3 System and method for explosives detection |
| 07/06/2006 | WO2005067633B1 Method and apparatus for presentation of noninvasive glucose concentration information |
| 07/06/2006 | WO2005036369A3 Database for microbial investigations |
| 07/06/2006 | WO2005034736A3 Generation of biochemical images and methods of use |
| 07/06/2006 | WO2005024374A3 Process and device based on intelligent systems - artificial intelligence - artificial neural nets, for determination and control in real time of contaminants in physical and/or chemical and/or biological systems |
| 07/06/2006 | WO2005017118A3 Sulfs as modifiers of the beta catenin pathway and methods of use |
| 07/06/2006 | WO2005003326A3 Artificial receptors including reversibly immobilized building blocks and methods |
| 07/06/2006 | WO2004112565A3 Diagnosis and treatment of liver, pulmonary and cardiac fibrosis |
| 07/06/2006 | WO2004101761A3 METHODS FOR THE IDENTIFICATION OF INHIBITORS OF CAX1-LIKE Ca+2/H+ANTIPORTER ACTIVITY IN PLANTS |
| 07/06/2006 | WO2004066926A3 Methods and compositions for modulating t lymphocytes |
| 07/06/2006 | WO2004034031A3 A method for diagnosis and prognosis of multiple sclerosis |
| 07/06/2006 | WO2004013157A3 REDUCING NgR-p75 MEDIATED BY INHIBITION OF AXON REGENERATION |
| 07/06/2006 | US20060150264 Differential gene expression in schizophrenia |
| 07/06/2006 | US20060150259 Model of bone disease amenable to high-throughput screening |
| 07/06/2006 | US20060149521 Modulating nuclear receptor coactivator binding |
| 07/06/2006 | US20060149164 Liquid sampler and method |
| 07/06/2006 | US20060149143 Optical-based sensing devices |
| 07/06/2006 | US20060149034 Homing peptides to receptors of heart vasculature |
| 07/06/2006 | US20060149033 IGF antagonist peptides |
| 07/06/2006 | US20060148807 Pyrrolo[1,2b]pyridazine compounds and their uses |
| 07/06/2006 | US20060148777 1,5-Bis-((2-dimethylamino-N-oxide)ethyl)amino)-4,8-dihydroxyanthracene-9,10-dione; DRAQ5 dyes;analyzing cells/biological material and detecting emitted fluorescence signal; cell permeant DNA-interactive agents providing a fluorescence signature into the infra red spectra; red-line emitting lasers |
| 07/06/2006 | US20060148739 Method of evaluating compound efficacious in treating obesity |
| 07/06/2006 | US20060148712 Monocyte chemoattractant activity of galectin-3 |
| 07/06/2006 | US20060148709 Neuroprotective properties of GDF-15, a novel member of the TGF-Beta superfamily |
| 07/06/2006 | US20060148708 C5a receptor |
| 07/06/2006 | US20060148692 Novel protein and its dna |
| 07/06/2006 | US20060148690 Secreted peptides |
| 07/06/2006 | US20060148688 Use of na, k-atpase a-and b-subunits in bladder cancer detection and drug screening |
| 07/06/2006 | US20060148104 Detection of ion channel or receptor activity |
| 07/06/2006 | US20060148103 Highly sensitive biological assays |
| 07/06/2006 | US20060148102 Apparatuses and methods for assaying analytes using photoelectrochemical labels |
| 07/06/2006 | US20060148101 Fluorescent ligands for GPCR arrays |
| 07/06/2006 | US20060148100 Real time binding analysis of antigens on a biosensor surface |
| 07/06/2006 | US20060148099 Sensor device for determining protein aggregation |
| 07/06/2006 | US20060148098 Method and kit for detecting antigens |
| 07/06/2006 | US20060148097 Test strip for immunochromatography |
| 07/06/2006 | US20060148096 Assay device, system and method |
| 07/06/2006 | US20060148095 Method for high-throughput integrated chemical and biochemical reactions |
| 07/06/2006 | US20060148093 Detection and quantification of modified proteins |
| 07/06/2006 | US20060148092 each probe structure being adapted to undergo a thermoelastic response when excited by temporarily varying electromagnetic radiation, the thermoelastic response being a function of physical and/or chemical properties of the probe structure and a sample material binding thereto; DNA sequencing |
| 07/06/2006 | US20060148091 Method for determination of absolute configuration of chiral compounds |
| 07/06/2006 | US20060148090 Metal chelating compositions for protein purification, detection or binding |
| 07/06/2006 | US20060148089 Small scale ideal kinetic reactor to evaluate full size industrial catalysts |
| 07/06/2006 | US20060148069 Biochemical container |
| 07/06/2006 | US20060148063 for continuous workflow processing of biological samples; includes network capability for connectivity with additional equipment for receiving or transmitting pertinent data via the network; automated processing |
| 07/06/2006 | US20060148056 Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 07/06/2006 | US20060148055 Oxidised fragments of apolioprotein B and their uses |
| 07/06/2006 | US20060148052 Production of polyketides in bacteria and yeast |
| 07/06/2006 | US20060148037 amino acid sequence is encoded by nucleotide sequences, a potassium channel modulators; cell producing a membrane protein associated with ionic mobility for detecting and preventing pancreatic disorders; diagnose diabetes; producing biodrug for treating type 1 and type 2 diabetes |
| 07/06/2006 | US20060148032 Novel phosphoprotein |
| 07/06/2006 | US20060148030 Nuclear receptor err y 3 |
| 07/06/2006 | US20060148028 Method for detecting microbe or cell |
| 07/06/2006 | US20060148024 Determination of enzymatic activity utilizing paramagnetic multivalent and fluorescent quenching; high throughput assay |
| 07/06/2006 | US20060148023 Affinity labeling of serine proteases for simultaneous detection of multiple serine protease activity levels |
| 07/06/2006 | US20060148018 Insulin-like growth factor binding protein-4 protease |
| 07/06/2006 | US20060148017 Compositions and methods for monitoring enzyme activity |
| 07/06/2006 | US20060148016 Nanoparticle for bioaffinity assays |
| 07/06/2006 | US20060148015 Lectin pathway deficiency assay |
| 07/06/2006 | US20060148014 Tubulin isotype screening in cancer therapy using hemiasterlin analogs |
| 07/06/2006 | US20060148013 use of RL9/RL10 protein and the polynucleotides encoding RL9/RL10 protein, e.g., in diagnosing and treating tumor, as well as the pharmaceutical composition containing RL9/RL10 protein or the antibody against it |
| 07/06/2006 | US20060148012 Assay for identifying antibody producing cells |
| 07/06/2006 | US20060148011 Diagnosing prostate cancer by contacting a biological fluid sample (plasma) or prostatic tissue specimen from the subject with an antibody which binds to SEQ ID NO: 1, detecting binding of the antibody in the specimen and correlating the detected binding to prostate cancer |
| 07/06/2006 | US20060148010 Isolation and purification of P. falciparum merozoite protien-142 vaccine |
| 07/06/2006 | US20060148009 Prediction and assessment of immunogenicity |
| 07/06/2006 | US20060148008 Method of characterizing dendritic cells |
| 07/06/2006 | US20060148007 Using cells which over express g-protein coupled receptors as drug screening tools; high throughput and signal transduction assays |
| 07/06/2006 | US20060148006 Assay solution compositions and methods for GPCR arrays |
| 07/06/2006 | US20060148005 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 07/06/2006 | US20060148004 Peptide sequence tags and method of using same |
| 07/06/2006 | US20060148003 Peptide sequence tags and method of using same |
| 07/06/2006 | US20060148002 Methods and compositions for the treatment and diagnosis of body weight disorders |
| 07/06/2006 | US20060148001 Compositions and methods for treating female fertility |
| 07/06/2006 | US20060148000 Methods for identifying modulators of N-type ion channel inactivation |
| 07/06/2006 | US20060147999 Method and apparatus for homology-based complex detection in a protein-protein interaction network |
| 07/06/2006 | US20060147998 Method for diagnosing and monitoring critically ill patients |
| 07/06/2006 | US20060147993 Reliable protein-coupled receptor (GPCR) microarrays on porous substrates for structural or functional analyses of GPCRs |
| 07/06/2006 | US20060147992 Method for detection of bioactive peptides |
| 07/06/2006 | US20060147991 DNA chip and reactive solid carrier |
| 07/06/2006 | US20060147988 Vertebrate transmembrane protein (UNC-5 protein) for use in diagnosis, prevention and treatment of nervous system disorders |
| 07/06/2006 | US20060147987 Bivalent binding molecules of 7 transmembrane G protein-coupled receptors |
| 07/06/2006 | US20060147986 Gene and protein libraries and methods relating thereto |
| 07/06/2006 | US20060147980 Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes |
| 07/06/2006 | US20060147978 Methods and compositions for screening for altered cellular phenotypes |
| 07/06/2006 | US20060147977 Device and methods for tracking conditions in an assay |
| 07/06/2006 | US20060147975 Method for assaying protein-protein interaction |
| 07/06/2006 | US20060147973 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/06/2006 | US20060147970 Biomolecule detector and detection method using the same |
| 07/06/2006 | US20060147959 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |
| 07/06/2006 | US20060147951 "STRAP" and "STEAP" (six transmembrane epithelial antigen of the prostate) |